107.521 articles found

[Analysis of Parkinson's EEG based on the complexity measure].

Chen Z, Wu W, Tong Q, Yan X.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi · 1999-06-01

PMID: 12552667

Protective and symptomatic strategies for therapy of Parkinson's disease.

Blandini F, Greenamyre JT.

Drugs Today (Barc) · 1999-06-01

DOI: 10.1358/dot.1999.35.6.544933PMID: 12973393

Ayurvedic composition for the treatment of disorders of the nervous system including Parkinson's disease

PRUTHI SOM C, PRUTHY PUNEET.

· 1999-05-29

CABERGOLINE AND PRAMIPEXOLE FOR TREATING CNS DISEASES, ESPECIALLY PARKINSON'S DISEASE

GOMEZ-MANCILLA Baltazar.

· 1999-05-07

CABERGOLINE AND PRAMIPEXOLE FOR TREATING CNS DISEASES, ESPECIALLY PARKINSON'S DISEASE

GOMEZ-MANCILLA Baltazar.

· 1999-05-07

Pramipexole for treating CNS diseases, especially Parkinson's disease

GOMEZ-MANCILLA BALTAZAR.

· 1999-05-07

CABERGOLINE AND PRAMIPEXOLE FOR TREATING CNS DISEASES, ESPECIALLY PARKINSON'S DISEASE

GOMEZ-MANCILLA BALTAZAR.

· 1999-05-07

Cabergoline and pramipexole: new uses in Parkinson's disease, multisystemic atrophy (MSA) or progressive supranuclear palsy (PSP)

GOMEZ-MANCILLA BALTAZAR.

· 1999-05-07

COMBINED TREATING OF CNS DISEASES, ESPECIALLY PARKINSON'S DISEASE BY COMBINED ADMINISTRATION OF CABERGOLINE AND PRAMIPEXOLE

GOMEZ-MANCILLA BALTAZAR.

· 1999-05-07

Parkinsonism after taking ecstasy.

Mintzer S, Hickenbottom S, Gilman S.

N Engl J Med · 1999-05-01

DOI: 10.1056/nejm199905063401817PMID: 10328712

Cytochrome P4502D6 (debrisoquine 4-hydroxylase) and Parkinson's disease in Chinese and Caucasians.

Ho SL, Kung MH, Li LS, Lauder IJ, Ramsden DB.

Eur J Neurol · 1999-05-01

DOI: 10.1046/j.1468-1331.1999.630323.xPMID: 10210913

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debré P, Agid Y, Dugas B, Hirsch EC.

J Neurosci · 1999-05-01

DOI: 10.1523/jneurosci.19-09-03440.1999PMID: 10212304